Investigation of allele and genotype frequencies of CYP2C9, CYP2C19 and VKORC1 in Iran

被引:0
作者
Negar Azarpira
Soha Namazi
Fatemeh Hendijani
Maryam Banan
Masumeh Darai
机构
[1] Shiraz University of Medical Sciences,Transplant Research Center
[2] Faculty of Pharmacy,Department of Pathology, Department of Pharmacotherapy
[3] Shiraz University of Medical Sciences,undefined
来源
Pharmacological Reports | 2010年 / 62卷
关键词
Iranian; genotype;
D O I
暂无
中图分类号
学科分类号
摘要
Research has shown that there are significant ethnic variations in the frequency of highly functional mutations in genes coding for metabolic enzymes. However, few studies have examined the frequency distribution of major allelic variations within the population of Iran. The present study focused on the genotype profile of southern Iranians in order to compare the allelic frequencies of CYP2C9, CYP2C19, and VKORC1–1639G>A (all of which have been shown to have significant roles in the metabolism of warfarin) with those of other populations. Therefore, genotyping was carried out on 150 subjects (50 healthy volunteers and 100 outpatient subjects) by polymerase chain reaction-restriction length polymorphism (PCR-RFLP). Findings indicated both similarities and differences in the distribution of polymorphic alleles of CYP2C9, CYP2C19 and VKORC1 between southern and northern Iranians. For example, the frequency of CYP2C9*3 among southern Iranians (9.8%) was found to be similar to the frequency found among Caucasians (in this case, Italians) (9.7%) but was higher than the frequency found among Africans (1%), Japanese (2.3%), and northern Iranians (0%). These findings confirmed significant inter-ethnic differences in CYP2C9 frequencies between southern and northern Iranians The reported frequency of CYP2C9*2 in our subjects (25.3%) was different from the frequencies seen in Caucasian (10–13%), African (2%) and Asian (0%) populations. The CYP2C19*2 and CYP2C19*3 allelic frequencies were similar to the Caucasian population. For VKORC1, the allelic frequency of–1639A (55.6%) was in accordance with Caucasian, but different from Chinese (96%) and African-American populations (13%).
引用
收藏
页码:740 / 746
页数:6
相关论文
共 143 条
[1]  
Adithan C(2003)Allele and genotype frequency of CYP2C9 in Tamilnadu population Eur J Clin Pharmacol 59 707-709
[2]  
Gerard N(2007)Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population Fundam Clin Pharmacol 21 419-426
[3]  
Vasu S(2005)A polymorphism in Blood 105 645-649
[4]  
Balakrishnan R(1994) gene is associated with an inter-individual variability in the dose-anticoagulant effect of warfarin Mol Pharmacol 46 594-598
[5]  
Shashindran CH(2007)Identification of a new genetic defect responsible for the polymorphism of ( Iran J Immunol 4 85-93
[6]  
Krishnamoorthy R(2007))-mephenytoin metabolism in Japanese Int J Immunogenet 34 457-463
[7]  
Arvanitidis K(2004)HLA class II genetic diversity in Arabs and Jews of Iran Tissue Antigens 64 581-587
[8]  
Ragia G(2003)HLA class II similarities in Iranian Kurds and Azeris Eur J Clin Pharmacol 59 303-312
[9]  
Iordanidou M(1994)Molecular analysis of HLA allele frequencies and haplotypes in Baloch of Iran compared with related populations of Pakistan Pharmacogenetics 4 285-299
[10]  
Kyriaki S(2002)Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population Br J Clin Pharmacol 53 596-603